Real-World Effectiveness, Tolerability, and Safety of Dolutegravir/Lamivudine in Korea by Ki Hyun Lee, Jinnam Kim, Jung Ah Lee, Chang Hyup Kim, Jin Young Ahn, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Joon-Sup Yeom, Young Goo Song, Jung Ho Kim

Subjects: “…dolutegravir/lamivudine…”
Get full text

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV by Maria Mazzitelli, Lolita Sasset, Samuele Gardin, Davide Leoni, Mattia Trunfio, Vincenzo Scaglione, Daniele Mengato, Elena Agostini, Eleonora Vania, Cristina Putaggio, Annamaria Cattelan

Subjects: Get full text

Role of Dolutegravir/Lamivudine in the Management of Pregnant People Living with HIV-1: A Narrative Review by William R. Short, Parul Patel, Gustavo Verdier, Ana Puga, Vani Vannappagari, Annemiek de Ruiter, Bryn Jones

Subjects: Get full text

Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study by Hernando Knobel, Esperanza Cañas-Ruano, Ana Guelar, Pablo Knobel, Judit Villar-García, Alicia González-Mena, Ceclia Canepa, Itziar Arrieta-Aldea, Augustin Marcos, Agustí Abalat-Torrres, Roberto Güerri-Fernández

Subjects: Get full text

Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens by Julie Priest, Guillaume Germain, François Laliberté, Mei Sheng Duh, Malena Mahendran, Iman Fakih, Alan Oglesby

Subjects: “…Dolutegravir/lamivudine…”
Get full text